Related Experiment Videos
[Myasthenia in children: long-term course]
H Descamps1, J Bataille, B Estournet
1Service de Réanimation Infantile, Rééducation Neuro-Respiratoire, Hôpital Raymond-Poincaré, Garches.
Annales De Medecine Interne
|January 1, 1987
Summary
For pediatric myasthenia gravis, thymectomy and steroid therapy offer limited benefits and potential dependence. Researchers suggest avoiding routine thymectomy and minimizing steroid use in children with myasthenia gravis.
Area of Science:
- Neurology
- Pediatrics
- Immunology
Context:
- Pediatric myasthenia gravis presents unique challenges in diagnosis and treatment.
- Respiratory complications are common, affecting over 60% of pediatric patients.
- Familial and pure ophthalmic forms were not observed in this cohort.
Purpose:
- To evaluate the long-term efficacy and safety of thymectomy and steroid therapy in pediatric myasthenia gravis.
- To determine optimal treatment strategies for children diagnosed with myasthenia gravis.
- To assess the impact of surgical intervention versus conservative management.
Summary:
- A 10-year follow-up of 23 children with myasthenia gravis revealed limited efficacy of thymectomy, with symptom stability or worsening in 75% post-surgery.
- Steroid therapy showed mixed results: ineffective short courses in younger children and cortico-dependence in 4 of 6 older children.
- Complete remission rates were similar between thymectomized and non-thymectomized groups at 7 years post-surgery.
Impact:
- Findings challenge the routine use of thymectomy for pediatric myasthenia gravis.
- Suggests a conservative approach, minimizing steroid therapy due to potential adverse effects like cortico-dependence.
- Highlights the need for individualized treatment plans based on patient age and disease severity.